Study Finds Herpes Drug Fails to Reduce HIV Risk

by Thilaka Ravi on  January 21, 2010 at 12:49 PM Drug News   - G J E 4
A widely used treatment for the herpes virus does not cut the risk of transmission of HIV-AIDS, according to a medical study published Wednesday after a five-year trial.
 Study Finds Herpes Drug Fails to Reduce HIV Risk
Study Finds Herpes Drug Fails to Reduce HIV Risk

The study showed that people who had both HIV and the virus responsible for the most common form of herpes, HSV-2, did not cut the chance of passing it on by taking twice-daily doses of acyclovir.

The research published in the New England Journal of Medicine online looked at more than 3,400 African couples -- one of each who had HIV and one of whom did not.

There were 41 infections amongst those who took acyclovir and 43 amongst those given a placebo, which was not a significant difference, the study said.

Five earlier studies had demonstrated it was possible to reduce HIV levels in the blood and genital tract through treatment for the herpes virus, but did not show if this translated into a reduction in HIV transmission, it said.

Up to 90 percent of people with HIV also have an HSV-2 infection, but most people who are infected with the herpes virus are unaware because symptoms can be mild or absent, the study said.

Several studies showed that frequent herpes recurrences increase the amount of HIV in the blood and genital tract, said the study led by the University of Washington in Seattle and funded by the Bill and Melinda Gates Foundation.

The herpes virus also attracts immune cells called CD4 T-cells to the genital region, which HIV uses to establish or pass infection, said the study.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like